logo
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time
HIV protease inhibitors block adipocyte differentiation independently of lamin A/C
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients
Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus
Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques
Expression of a novel cytokine, IL-4delta2, in HIV and HIV–tuberculosis co-infection
Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients
MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study
Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients
Molecular testing of multiple HIV-1 transmissions in a criminal case
Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women
The incidence and prevalence of orphanhood associated with parental HIV infection: a population-based study in Rakai, Uganda
Prolonged breast-feeding and mortality up to two years post-partum among HIV-positive women in Zambia
Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo
Is HIV-1 evolving to a less virulent (pathogenic) virus?
Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir
Evaluation of the anti-HIV activity of statins
Use of bilirubin as a marker of adherence to atazanavir-based antiretroviral therapy
Response to hepatitis A vaccine in HIV patients in the HAART era
Susceptibility of Chinese rhesus monkeys to SIV infection
Response to ‘Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients’ by Mariné-Barjoan et al.
Response to comments of Paul et al.
More to positive prevention than sexually transmitted infection screening
HIV and achalasia
Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin's B-cell lymphoma
Long-term persistence of HIV with drug resistance after CD4 cell count-guided structured treatment interruption
Mycobacterium africanum: a new opportunistic pathogen in HIV infection?
Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance
HIV and infant feeding: a complex issue in resource-limited settings
Reply to ‘Mode of infant feeding and HIV infection in children in a program for prevention of mother-to-child transmission in Uganda’ by Magoni et al.
Increased risk of infant HIV infection with early mixed feeding
Authors' response to ‘HIV and infant feeding: a complex issue in resource-limited settings’ by Becquet and Leroy, to the letter to the editors by Coutsoudis et al., and to ‘Increased risk of infant HIV infection with early mixed feeding’ by Piwoz and Humphrey
Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens